RJ-31, a 61-year-old patient, likely had a small T-cell clone carrying a TET2 mutation, which posed a hidden risk before being used for CAR-T manufacturing—leading to the uncontrolled expansion of CAR-T cells derived from autologous lymphocytes upon viral infection. The gene discussed is TET2; the disease is viral infectious disease.